Browsing by Subject "Gender-affirming care"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience
    (Taylor & Francis, 2023-12-15) Fuqua, John S.; Shi, Eda; Eugster, Erica A.; Pediatrics, School of Medicine
    Background: Androgen blockers are an essential part of gender affirming care in post-pubertal transfeminine patients. Bicalutamide is a highly potent androgen receptor blocker that is used primarily in adults. We aimed to review our experience with the use of bicalutamide in transgender adolescents who were assigned male at birth. Methods: A retrospective review of medical records of transfeminine patients treated with bicalutamide during an 8-year period was conducted. Results: Forty patients, aged 15.5 ± 1.55 years were identified, of whom 21 (53%) were started on bicalutamide alone and 19 were started concurrently on estrogen. In patients on bicalutamide alone, 90.4% reported breast development at their first follow up visit, which occurred at a median of 7.1 months. Patients were treated for 29.4 ± 18.2 months. No episodes of liver toxicity related to bicalutamide were seen. Conclusions: Although these results are preliminary, bicalutamide appears to be a safe option for androgen blockade in transgender girls.
  • Thumbnail Image
    Item
    Transgender Youths' Perspectives on Telehealth for Delivery of Gender-Affirming Care
    (Elsevier, 2021) Sequeira, Gina M.; Kidd, Kacie M.; Coulter, Robert W. S.; Miller, Elizabeth; Fortenberry, Dennis; Garofalo, Robert; Richardson, Laura P.; Ray, Kristin N.; Pediatrics, School of Medicine
    Purpose: We aimed to examine transgender youths' interest in receiving gender-affirming care via telemedicine or through primary care with telehealth support. Methods: We surveyed 12- to 26-year-old transgender youth receiving care in a multidisciplinary gender clinic. Descriptive statistics and bivariate analyses were used to assess relationships between demographic and gender-related characteristics and interest in receiving care via telemedicine. Results: Almost half (47%) of the 204 youth surveyed expressed interest in receiving gender care via telemedicine. Additionally, youth with lower levels of perceived parental support were more likely to express an interest in utilizing telemedicine (p = .001). Approximately half (45%) of youth were interested in receiving gender care in the primary care setting, with a majority expressing willingness to do so if their primary care provider had telehealth support. Conclusions: Many transgender youth expressed interest in receiving gender care via telehealth, particularly for ongoing care and monitoring. Increased interest in telemedicine was seen among youth with lower perceived parental support.